Status:
RECRUITING
Evaluating the Impact of Limited Compared With Intense Post-Operative Surveillance on Patient-Reported Outcomes in Patients With Stage II-III Soft Tissue Sarcoma of the Trunk and Extremities
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
This phase II trial studies how anxiety is affected by 2 types of follow-up after surgery, limited follow-up and intense follow-up, in patients with stage II-III soft tissue sarcoma of the trunk and e...
Detailed Description
PRIMARY OBJECTIVE: I. To evaluate whether a risk-based limited follow-up surveillance is associated with reduced patient anxiety compared to risk-based intense surveillance. SECONDARY OBJECTIVE: I....
Eligibility Criteria
Inclusion
- I
- ≥18 years old
- Completion of sarcoma therapy (chemotherapy, radiation therapy and/or surgery) within 8-14 weeks of study enrollment
- Willingness to complete surveys x 2 years
Exclusion
- Documented metastatic disease at the time of enrollment
- Non-English-speaking patients
- Pregnant women will be included in this clinical trial.
Key Trial Info
Start Date :
December 28 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
227 Patients enrolled
Trial Details
Trial ID
NCT04751409
Start Date
December 28 2020
End Date
December 31 2027
Last Update
September 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
M D Anderson Cancer Center
Houston, Texas, United States, 77030